← FDA DRUG APPROVALS

FDA ANDA · ANDA076433

FENOFIBRATE

Sponsor: RHODES PHARMS

APPLICATION
ANDA076433
TYPE
ANDA
ORIGINAL APPROVAL
2005-05-13
LATEST ACTION
2013-08-06
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription

Products

FENOFIBRATEPrescription
FENOFIBRATE 54MG · TABLET · ORAL
FENOFIBRATEPrescription
FENOFIBRATE 160MG · TABLET · ORAL

Approval history

2013-08-06Labeling · Supplement 6 · standardAP
2011-05-08Labeling · Supplement 4AP
2010-04-30Labeling · Supplement 3AP
2010-01-04Labeling · Supplement 2AP
2005-05-13OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →